Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
We will set up a few reminders to ensure you dont miss your renewal window
Chronic kidney disease and type 2 diabetes
Available:
At 3 and 12 months post-index, 1.5 mg dulaglutide was the most common dosage formulation (81% and 79%, respectively), with dispensation of dulaglutide 3.0 mg and 4.5 mg less common throughout follow-up
Efficacy endpoints were change from baseline in HbA 1c and body weight (and, for the separate PIONEER 8 subgroup analysis, change from baseline in insulin dose) at the planned end of treatment (weeks 26, 52 or 78, according to the trial)
Bad reactions to semaglutide Bad reactions to semaglutide can occur, and some users have experienced severe and life-altering side effects after taking the drug
